0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Original Article |  FREE
Carsten Bøcker Pedersen, MSc; Preben Bo Mortensen, DMSc
Arch Gen Psychiatry. 2001;58(11):1039-1046. doi:10.1001/archpsyc.58.11.1039.

Original Article |  FREE
Anne T. Harvey, PhD; Richard L. Rudolph, MD; Sheldon H. Preskorn, MD
Arch Gen Psychiatry. 2000;57(5):503-509. doi:10.1001/archpsyc.57.5.503.

News and Views | 
William E. Bunney Jr, MD; Daniel L. Azarnoff, MD; Byron W. Brown Jr, PhD; et al.
Arch Gen Psychiatry. 1999;56(4):349-352. doi:10.1001/archpsyc.56.4.349.

Sign in

Purchase Options

• Subscribe to the journal

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Neurology
Viewpoint  | 
How Critical Is the Blood-Brain Barrier to the Development of Neurotherapeutics?
Carmen Kut, BS; Stuart A. Grossman, MD; Jaishri Blakeley, MD
JAMA Internal Medicine
Invited Commentary  | 
Improving the Success of Treating Tobacco Smokers
Nancy A. Rigotti, MD
JAMA Internal Medicine
Original Investigation  | 
Increasing Varenicline Dose in Smokers Who Do Not Respond to the Standard Dosage:  A Randomized Clinical Trial
Peter Hajek, PhD; Hayden McRobbie, MB, ChB, PhD; Katherine Myers Smith, DPsych; et al.
JAMA Ophthalmology
Original Investigation  | 
A 50% vs 30% Dose of Verteporfin (Photodynamic Therapy) for Acute Central Serous Chorioretinopathy:  One-Year Results of a Randomized Clinical Trial
Mingwei Zhao, MD; Feng Zhang, MD; Youxin Chen, MD; et al.